Advertisement

Marked ST-segment elevations during regadenoson pharmacologic nuclear stress testing

  • Nicholas ChanEmail author
  • Vikaas Kataria
  • Beom Soo Kim
  • Peter Raimondi
  • John N. Makaryus
Images that Teach
  • 33 Downloads

Notes

Disclosures

On behalf of all authors, the corresponding author states that there is no conflict of interest or financial disclosures relevant to this article.

References

  1. 1.
    Qamruddin S, Huang HW, Mehra A, Bonyadlou S, Yoon AJ. ST segment elevation ECG changes during pharmacologic stress with regadenoson. Clin Nucl Med. 2016;41(1):62–4.CrossRefGoogle Scholar
  2. 2.
    Peters MN, Bhattasli O, Burchett AR, Howell LA, Turnage TA, Katz MJ, Delafontaine P, Irimpen AM. Coronary angiographic significance of hyperacute ST-T changes associated with regadenoson stress. Proc (Bayl Univ Med Cent). 2013;26(3):277–9.CrossRefGoogle Scholar
  3. 3.
    Hsi DH, Marreddy R, Moshiyakhov M, Luft U. Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. J Nucl Cardiol. 2013;20(3):481–4.CrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2019

Authors and Affiliations

  • Nicholas Chan
    • 1
    • 2
    Email author
  • Vikaas Kataria
    • 1
    • 2
  • Beom Soo Kim
    • 1
    • 2
  • Peter Raimondi
    • 1
    • 2
  • John N. Makaryus
    • 1
    • 2
    • 3
  1. 1.Department of CardiologyNorth Shore University HospitalManhassetUSA
  2. 2.Zucker School of Medicine at Hofstra/NorthwellHempsteadUSA
  3. 3.The Feinstein Institute for Medical Research at Northwell HealthManhassetUSA

Personalised recommendations